Computer modeling for pharmacological treatments for dystonia.
dc.contributor.author | Neymotin, Samuel A | |
dc.contributor.author | Dura-Bernal, Salvador | |
dc.contributor.author | Moreno, Herman | |
dc.contributor.author | Lytton, William W | |
dc.date.accessioned | 2023-04-10T16:33:52Z | |
dc.date.available | 2023-04-10T16:33:52Z | |
dc.date.issued | 2017-03-31 | |
dc.identifier.citation | Neymotin SA, Dura-Bernal S, Moreno H, Lytton WW. Computer modeling for pharmacological treatments for dystonia. Drug Discov Today Dis Models. 2016 Spring;19:51-57. doi: 10.1016/j.ddmod.2017.02.003. Epub 2017 Mar 31. PMID: 28983321; PMCID: PMC5624716. | en_US |
dc.identifier.issn | 1740-6757 | |
dc.identifier.doi | 10.1016/j.ddmod.2017.02.003 | |
dc.identifier.pmid | 28983321 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/8571 | |
dc.description.abstract | Dystonia is a movement disorder that produces involuntary muscle contractions. Current pharmacological treatments are of limited efficacy. Dystonia, like epilepsy is a disorder involving excessive activty of motor areas including motor cortex and several causal gene mutations have been identified. In order to evaluate potential novel agents for multitarget therapy for dystonia, we have developed a computer model of cortex that includes some of the complex array of molecular interactions that, along with membrane ion channels, control cell excitability. | |
dc.language.iso | en | en_US |
dc.relation.url | https://www.sciencedirect.com/science/article/abs/pii/S1740675717300099 | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | Computer modeling for pharmacological treatments for dystonia. | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | Drug discovery today. Disease models | en_US |
dc.source.volume | 19 | |
dc.source.beginpage | 51 | |
dc.source.endpage | 57 | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | Netherlands | |
dc.description.version | AM | en_US |
refterms.dateFOA | 2023-04-10T16:33:53Z | |
html.description.abstract | Dystonia is a movement disorder that produces involuntary muscle contractions. Current pharmacological treatments are of limited efficacy. Dystonia, like epilepsy is a disorder involving excessive activty of motor areas including motor cortex and several causal gene mutations have been identified. In order to evaluate potential novel agents for multitarget therapy for dystonia, we have developed a computer model of cortex that includes some of the complex array of molecular interactions that, along with membrane ion channels, control cell excitability. | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Physiology and Pharmacology | en_US |
dc.description.department | Nathan Kline Institute for Psychiatric Research | en_US |
dc.description.degreelevel | N/A | en_US |
dc.identifier.journal | Drug discovery today. Disease models |